Page 60 - ARNM-2-4

Advances in Radiotherapy
& Nuclear Medicine Efficacy of stereotactic radiotherapy

doi: 10.1016/j.ijrobp.2020.10.011 doi: 10.1016/j.lungcan.2010.05.003
14. Dunne EM, Fraser IM, Liu M. Stereotactic body radiation 24. Billing PS, Miller DL, Allen MS, Deschamps C, Trastek VF,
therapy for lung, spine and oligometastatic disease: Current Pairolero PC. Surgical treatment of primary lung cancer
evidence and future directions. Ann Transl Med. 2018;6(14):283. with synchronous brain metastases. J Thorac Cardiovasc
doi: 10.21037/atm.2018.06.40 Surg. 2001;122(3):548-553.
15. Siddiqui F, Patel M, Khan M, et al. Stereotactic body doi: 10.1067/mtc.2001.116201
radiation therapy for primary, recurrent, and metastatic 25. Mohammad WM, Balaa FK. Surgical management
tumors in the head-and-neck region. Int J Radiat Oncol Biol of colorectal liver metastases. Clin Colon Rectal Surg.
Phys. 2009;74(4):1047-1053. 2009;22(4):225-232.
doi: 10.1016/j.ijrobp.2008.09.022 doi: 10.1055/s-0029-1242462
16. Hsieh RW, Borson S, Tsagianni A, Zandberg DP. 26. Haddad AJ, Bani Hani M, Pawlik TM, Cunningham SC.
Immunotherapy in recurrent/metastatic squamous cell Colorectal liver metastases. Int J Surg Oncol.
carcinoma of the head and neck. Front Oncol. 2021;11:705614. 2011;2011:285840.
doi: 10.3389/fonc.2021.705614 doi: 10.1155/2011/285840
17. Brockstein B, Haraf DJ, Rademaker AW, et al. Patterns of 27. Liu E, Stenmark MH, Schipper MJ, et al. Stereotactic body
failure, prognostic factors and survival in locoregionally radiation therapy for primary and metastatic liver tumors.
advanced head and neck cancer treated with concomitant Transl Oncol. 2013;6(4):442-446.
chemoradiotherapy: A 9-year, 337-patient, multi-
institutional experience. Ann Oncol. 2004;15(8):1179-1186. doi: 10.1593/tlo.12448
doi: 10.1093/annonc/mdh308 28. Mantel F, Glatz S, Toussaint A, Flentje M, Guckenberger M.
Long-term safety and efficacy of fractionated stereotactic
18. Wong SJ, Machtay M, Li Y. Locally recurrent, previously body radiation therapy for spinal metastases. Strahlenther
irradiated head and neck cancer: Concurrent re-irradiation Onkol. 2014;190(12):1141-1148.
and chemotherapy, or chemotherapy alone. J Clin Oncol.
2006;24(17):2653-2658. doi: 10.1007/s00066-014-0706-1
doi: 10.1200/JCO.2005.05.3850 29. Zhao X, Zhu X, Fei J, et al. Short-term outcomes and clinical
efficacy of Stereotactic Body Radiation Therapy (SBRT) in
19. Yokota T, Homma A, Kiyota N, et al. Immunotherapy for treatment of adrenal gland metastases from lung cancer.
squamous cell carcinoma of the head and neck. Jpn J Clin Radiat Oncol. 2018;13(1):205.
Oncol. 2020;50(10):1089-1096.
doi: 10.1186/s13014-018-1152-5
doi: 10.1093/jjco/hyaa139
30. Villaruz LC, Kubicek GJ, Socinski MA. Management of
20. Chen L, Mo DC, Hu M, Zhao SJ, Yang QW, Huang ZL. PD-1/ non-small cell lung cancer with oligometastasis. Curr Oncol
PD-L1 inhibitor monotherapy in recurrent or metastatic Rep. 2012;14(4):333-341.
squamous cell carcinoma of the head and neck: A meta-
analysis. Am J Otolaryngol. 2022;43(2):103324. doi: 10.1007/s11912-012-0240-1
doi: 10.1016/j.amjoto.2021.103324 31. Kim TH, Nam TK, Yoon SM, Kim TH, Choi YM, Seong J.
Stereotactic ablative radiotherapy for oligometastatic
21. Lau A, Yang WF, Li KY, Su YX. Systemic therapy in recurrent hepatocellular carcinoma: A multi-institutional retrospective
or metastatic head and neck squamous cell carcinoma- a study (KROG 20-04). Cancers (Basel). 2022;14(23):5848.
systematic review and meta-analysis. Crit Rev Oncol
Hematol. 2020;153:102984. doi: 10.3390/cancers14235848
doi: 10.1016/j.critrevonc.2020.102984 32. Schiff D, Messersmith H, Brastianos PK, et al. Radiation
therapy for brain metastases: ASCO guideline endorsement
22. Moskovitz J, Moy J, Ferris RL. Immunotherapy for
head and neck squamous cell carcinoma. Curr Oncol of ASTRO guideline. J Clin Oncol. 2022;40(20):2271-2276.
Rep. 2018;20(2):22. doi: 10.1200/JCO.22.00333
doi: 10.1007/s11912-018-0654-5 33. Niranjan A, Monaco E, Flickinger J, Lunsford LD. Guidelines
for multiple brain metastases radiosurgery. Prog Neurol Surg.
23. Pfannschmidt J, Dienemann H. Surgical treatment of
oligometastatic non-small cell lung cancer. Lung Cancer. 2019;34:100-109.
2010;69(3):251-258. doi: 10.1159/000493055

Volume 2 Issue 4 (2024) 8 doi: 10.36922/arnm.3391